FindTrial
Sign In

Preliminary Examination of the Mechanisms on Postprandial Glucose Level Suppressive Material - An open-label crossover study-

Preliminary Examination of the Mechanisms on Postprandial Glucose Level Suppressive Material - An open-label crossover study- - Preliminary Examination of the Mechanisms on Postprandial Glucose Level Suppressive Material - An open-label crossover study-

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052610
Enrollment
16
Registered
2023-10-26
Start date
2023-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Apoplus Station Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females in the age between 30 and 64 years (2) Subjects who can have explanations and examinations in a remote environment. (web conference system, web questionnaire, etc.) (3) Subjects who can come to the designated examination facility on the scheduled visit date. (4) Subjects who can submit the written informed consent form.

Exclusion criteria

Exclusion criteria: (1) Subjects who regularly consume pharmaceuticals or quasi-drugs that may affect the efficacy evaluation of the test food. (2) Subjects who continuously consume food for specified health use, functional foods, or health foods that may affect the efficacy evaluation of the test food. (3) Subjects whose lifestyle is scheduled to change drastically before or after the start of the study (including business trip, travel, etc. that will significantly change the rhythm of their daily life). (4) Subjects who are currently participating in another study as a study subject, who have participated in another study within 4 weeks of its completion, or who schedule to participate in another study during the study period. (5) Other subjects who are judged by the investigator as unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Cmax of blood glucose—

Countries

Japan

Contacts

Public ContactHiroki Yoshimura

Apoplus Station Co.,Ltd. CRO Department Clinical Operations Division

food-contact@apoplus.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026